BASAGLAR
-
Cipla partners with Eli Lilly & Company to market diabetes drug BASAGLAR
(“Cipla”) today announced its partnership with, Eli Lilly and Company (India) Pvt. Ltd., a 100% subsidiary of Eli Lilly and…
Read More »
(“Cipla”) today announced its partnership with, Eli Lilly and Company (India) Pvt. Ltd., a 100% subsidiary of Eli Lilly and…
Read More »